Published: 12/02/2020 13:25 GMT Johnson & Johnson (JNJ) - Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-stage Age-related Macular Degeneration.
Janssen Pharmaceuticals Inc- Financial Terms of Transaction With Hemera Biosciences Are Not Being Disclosed.
